Lisinopril dosing
Pro Research Analysisby 
Searched over 200M research papers for "lisinopril dosing"
Consensus Meter
Lisinopril Dosing: Insights from Recent Research
Introduction to Lisinopril Dosing
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is widely used for treating hypertension and heart failure. Understanding the optimal dosing of lisinopril is crucial for maximizing its therapeutic benefits while minimizing potential side effects. This article synthesizes findings from multiple studies to provide a comprehensive overview of lisinopril dosing in various patient populations.
Lisinopril Dosing in Hypertensive Children
Dose-Response Relationship in Children
A study involving 115 hypertensive children aged 6 to 16 years demonstrated a clear dose-response relationship for lisinopril. Children weighing less than 50 kg were administered doses of 0.625 mg, 2.5 mg, and 20 mg, while those weighing 50 kg or more received 1.25 mg, 5 mg, and 40 mg. The study found that an initial dose of 0.07 mg/kg effectively lowered blood pressure within two weeks, with higher doses resulting in greater reductions.
Pharmacokinetics in Pediatric Patients
Research on the pharmacokinetics of lisinopril in children and adolescents with normal to mildly reduced kidney function indicated that dosing should consider both body weight and estimated glomerular filtration rate (eGFR). The study suggested that lisinopril dosing adjustments should include eGFR on top of weight adjustments to optimize therapeutic outcomes.
Lisinopril Dosing in Adults with Essential Hypertension
Dose-Peak Effect Relationship
In adults with mild to moderate essential hypertension, a study evaluated the dose-peak effect relationship of lisinopril. Doses of 2.5 mg, 10 mg, 20 mg, and 80 mg were compared, revealing that 10 mg and 20 mg doses produced similar peak antihypertensive effects, which were greater than those of the 2.5 mg dose but less than the 80 mg dose. The study concluded that an initial dose of 20 mg should not pose a greater risk of first-dose symptomatic hypotension compared to a 10 mg dose.
Long-Term Efficacy and Safety
A multicenter study involving 216 patients with mild to moderate hypertension confirmed a linear dose-response relationship for lisinopril, with significant reductions in diastolic blood pressure observed at doses of 20 mg and 80 mg compared to lower doses and placebo. The study also found that lisinopril was well tolerated at doses up to 80 mg per day.
Lisinopril Dosing in Special Populations
Renoprotection in Diabetic Nephropathy
For type 1 diabetic patients with diabetic nephropathy, a study evaluated the renoprotective effects of high doses of lisinopril. Doses of 20 mg, 40 mg, and 60 mg were compared, with the 40 mg dose offering additional reductions in urinary albumin excretion rate (UAER) and blood pressure compared to the 20 mg dose. However, the 60 mg dose did not provide further benefits over the 40 mg dose.
Acute Ischemic Stroke
In patients with acute ischemic stroke, initiating lisinopril within 24 hours of the event was found to be effective and well-tolerated. A dose of 5 mg, increased to 10 mg if necessary, significantly reduced blood pressure without adverse effects on neurological and functional outcomes.
Conclusion
Lisinopril is a versatile and effective antihypertensive agent with a well-established dose-response relationship across various patient populations. In children, dosing should be based on body weight and eGFR. For adults with essential hypertension, doses of 10 mg to 20 mg are effective, with higher doses providing additional benefits in specific conditions like diabetic nephropathy. In acute settings such as ischemic stroke, lisinopril can be safely initiated at lower doses. These findings underscore the importance of individualized dosing to optimize therapeutic outcomes while ensuring patient safety.
Sources and full results
Most relevant research papers on this topic